Advanced search
Publication Cover
International Journal of General Medicine Volume 16, 2023 - Issue
Submit an article Journal homepage
196
Views
0
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

Risk Factors for Left Ventricular Hypertrophy in Patients with Diabetic Kidney Disease: A Multi-Center Study

Xiangdong Wang1 Department of Blood Purification, Baoding People’s Hospital, Baoding, 071030, People’s Republic of ChinaView further author information
,
Dongpo Zhu2 Department of Internal Medicine, Baoding People’s Hospital, Baoding, 071030, People’s Republic of ChinaView further author information
,
Leilei Peng1 Department of Blood Purification, Baoding People’s Hospital, Baoding, 071030, People’s Republic of ChinaView further author information
,
Yan Gao3 Department of Nephrology, Affiliated Hospital of Hebei University, Baoding, 071030, People’s Republic of ChinaView further author information
&
Xiaodong Li4 Department of Nephrology, Baoding No. 1 Central Hospital of Hebei Medical University, Baoding, 071000, People’s Republic of ChinaCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0002-9231-4853View further author information
ORCID Icon
Pages 1705-1712 | Received 12 Mar 2023, Accepted 01 May 2023, Published online: 08 May 2023

References

  • Sagoo MK, Gnudi L. Diabetic nephropathy: an overview. Methods Mol Biol. 2020;2067:3–7.
  • Oshima M, Shimizu M, Yamanouchi M, et al. Trajectories of kidney function in diabetes: a clinicopathological update. Nat Rev Nephrol. 2021;17:740–750. doi:10.1038/s41581-021-00462-y
  • Vasanth Rao VR, Tan SH, Candasamy M, et al. Diabetic nephropathy: an update on pathogenesis and drug development. Diabetes Metab Syndr. 2019;13(1):754–762. doi:10.1016/j.dsx.2018.11.054
  • Stewart MH, Lavie CJ, Shah S, et al. Prognostic implications of left ventricular hypertrophy. Prog Cardiovasc Dis. 2018;61:446–455. doi:10.1016/j.pcad.2018.11.002
  • Yildiz M, Oktay AA, Stewart MH, et al. Left ventricular hypertrophy and hypertension. Prog Cardiovasc Dis. 2020;63(1):10–21. doi:10.1016/j.pcad.2019.11.009
  • Bourdillon MT, Vasan RS. A contemporary approach to hypertensive cardiomyopathy: reversing left ventricular hypertrophy. Curr Hypertens Rep. 2020;22:85. doi:10.1007/s11906-020-01092-8
  • Nardi E, Mulè G, Giammanco A, et al. Left ventricular hypertrophy in chronic kidney disease: a diagnostic criteria comparison. Nutr Metab Cardiovasc Dis. 2021;31:137–144. doi:10.1016/j.numecd.2020.08.028
  • Brooks JE, Soliman EZ, Upadhya B. Is left ventricular hypertrophy a valid therapeutic target? Curr Hypertens Rep. 2019;21:47. doi:10.1007/s11906-019-0952-9
  • Iyengar SS, Ram CVS. Concentric vs eccentric left ventricular hypertrophy: does it matter? It is all “blood pressure centered”. Am J Hypertens. 2021;34:581–582. doi:10.1093/ajh/hpab037
  • Maron BJ, Rowin EJ, Maron MS. Is regression of left ventricular hypertrophy really a good thing for patients with hypertrophic cardiomyopathy? The emerging mavacamten story. Am J Cardiol. 2021;147:145–146. doi:10.1016/j.amjcard.2021.01.034
  • Xie X, Peng Z, Li H, et al. Association of urine albumin/creatinine ratio below 30 mg/g and left ventricular hypertrophy in patients with type 2 diabetes. Biomed Res Int. 2020;2020:5240153. doi:10.1155/2020/5240153
  • Wang J, Lv J, He K, et al. Association of left ventricular hypertrophy and functional impairment with cardiovascular outcomes and mortality among patients with chronic kidney disease, results from the C-STRIDE study. Nephrology. 2022;27:327–336. doi:10.1111/nep.14009
  • Al-Sharifi A, Mingher HM. Microalbuminuria and left ventricular hypertrophy in patients with essential hypertension. J Pak Med Assoc. 2019;69:S13–S16.
  • Jørgensen PG, Bieringsørensen T, Mogelvang R, et al. Presence of micro- and macroalbuminuria and the association with cardiac mechanics in patients with type 2 diabetes. Eur Heart J Cardiovasc Imaging. 2018;19:1034–1041. doi:10.1093/ehjci/jex231
  • Nagai H, Suzuki S, Ishii H, et al. Impact of low- grade albuminuria on left ventricular diastolic dysfunction. Ijc Metab Endocr. 2015;6:13–16. doi:10.1016/j.ijcme.2015.01.006
  • Chillawar S, Verna A, Acharya S, et al. Co-Relation of 24 Hours Proteinuria And Left Ventricular Hypertrophy in Hypertensive Patients.Iosr. J Dent Med Sci. 2017;16:1–8.
  • Xue-Wei H, Ke-Qiong D, Juan-Juan Q, et al. Association between lipid profiles and left ventricular hypertrophy: new evidence from a retrospective study. Chin Med Sci J. 2022;37:103–117. doi:10.24920/004066
  • Xiao FK, Li P, Han ZY, et al. Patients with dipper and nondipper high-normal blood pressure were associated with left ventricular mass. Int J Hypertens. 2021;2021:6946418. doi:10.1155/2021/6946418
  • Bjelakovic B, Stefanutti C, Vukovic V, et al. Lipid profile and left ventricular geometry pattern in obese children. Lipids Health Dis. 2020;19:109. doi:10.1186/s12944-020-01285-9
  • Zanib A, Anwar S, Saleem K, et al. Frequency of left ventricular hypertrophy among patients on maintenance hemodialysis by voltage criteria and its relationship with biophysical-chemical parameters. Cureus. 2020;12:e7426. doi:10.7759/cureus.7426

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.